HF
NMTR

HRT Financial’s 9 Meters Biopharma NMTR Stock Holding History

HRT Financial’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,249
Closed -$25K – 3592
2023
Q1 		$25K Sell
18,249
-24,281
-57% -$45.8K ﹤0.01% 2169
2022
Q4 		$53K Buy
42,530
+41,826
+5,941% +$95.4K ﹤0.01% 2114
2022
Q3 		$3K Buy
+704
New +$3.49K ﹤0.01% 2638
2022
Q1 		– Sell
-664
Closed -$13K – 4114
2021
Q4 		$13K Buy
+664
New +$14.9K ﹤0.01% 3002
2021
Q3 		– Sell
-1,223
Closed -$26K – 3922
2021
Q2 		$26K Sell
1,223
-27,447
-96% -$674K ﹤0.01% 2713
2021
Q1 		$670K Buy
+28,670
New +$881K 0.01% 1560

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

HRT Financial's NMTR Position: Q2 2023 in Review

HRT Financial sold out of 9 Meters Biopharma (NMTR) in Q2 2023, closing a stake of 18,249 shares — an estimated $25K sold.

HRT Financial first reported a position in NMTR in Q1 2021 and held it in 6 quarters. The position peaked at $670K in Q1 2021. 34 funds tracked by Wall St. Rank hold NMTR as of Q2 2023.

  • HRT Financial reported no remaining 9 Meters Biopharma position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 18,249 9 Meters Biopharma shares in Q2 2023, an estimated $25K.
  • HRT Financial first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 6 quarters.
  • HRT Financial's 9 Meters Biopharma position peaked at $670K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.